Screener
Sabra Healthcare SBRA Cash disbursed for acquisitions
Cash disbursed for acquisitions at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireRealEstate.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable and accrued liabilities | 2,113 | (4,706) |
| Net cash provided by operating activities | 98,362 | 80,263 |
| Cash flows from investing activities: | ||
| Acquisition of real estate and lease intangibles | (96,101) | (7,854) |
| Origination and fundings of loans receivable | — | (1,710) |
| Origination and fundings of preferred equity investments | (15) | (9) |
| Additions to real estate | (11,851) | (7,783) |
| Escrow deposits for potential investments | (430) | — |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's cash disbursed for acquisitions?
- Sabra Healthcare (SBRA) reported cash disbursed for acquisitions of $96.1M in Q1 2026.
- How has Sabra Healthcare's cash disbursed for acquisitions changed year-over-year?
- Sabra Healthcare's cash disbursed for acquisitions increased by 1123.6% year-over-year, from $7.85M to $96.1M.
- What is the long-term trend for Sabra Healthcare's cash disbursed for acquisitions?
- Over 3 years (2021 to 2025), Sabra Healthcare's cash disbursed for acquisitions has grown at a 65.8% compound annual growth rate (CAGR), from $99.45M to $452.93M.
Ask your AI about Sabra Healthcare's cash disbursed for acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude